European Equities Traded in the US as American Depositary Edge Higher in Wednesday Trading

MT Newswires Live12-12

European equities traded in the US as American depositary receipts were slightly higher late Wednesday morning, rising 0.3% to 1,347.42 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and telecommunications company VEON (VEON), which rose 0.5% and 1.3% respectively. They were followed by biotech firm BioNTech (BNTX) and internet browser company Opera (OPRA), which increased 1.6% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and oil and gas company TotalEnergies (TTE), which lost 3.3% and 3.8% respectively. They were followed by pharmaceutical company Ascendis Pharma (ASND) and electronics conglomerate Philips (PHG), which were down 0.6% and 1.1%, respectively.

From the UK and Ireland, the gainers were led by software firm Endava (DAVA) and financial services company Lloyds Banking Group (LYG), which advanced 2.4% and 3.2% respectively. They were followed by education company Pearson (PSO) and cruise line operator Carnival (CUK), which were up 3.3% and 1.9% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN), which fell 8%. They were followed by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Akari Therapeutics (AKTX), which dropped 0.5% and 1.5% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment